Recherche d'une infection congénitale à CMV orientée par le dépistage auditif néonatal: état des lieux un an après sa
Procès-verbal du Conseil Académique Réuni le mardi 4 mai Sous la présidence de M. Stéphane AZOULAY Vice-Président Formatio
![Editorial Board - European Annals of Otorhinolaryngology, Head and Neck Diseases - Journal - Elsevier Editorial Board - European Annals of Otorhinolaryngology, Head and Neck Diseases - Journal - Elsevier](http://ars.els-cdn.com/content/image/X18797296.jpg)
Editorial Board - European Annals of Otorhinolaryngology, Head and Neck Diseases - Journal - Elsevier
![Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer](https://i1.rgstatic.net/publication/358109984_Therapeutic_strategies_oncologic_and_swallowing_outcomes_and_their_predictive_factors_in_patients_with_locally_advanced_hypopharyngeal_cancer/links/61f0b3999a753545e2f8b928/largepreview.png)
Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer
Current Therapeutic Strategies in Patients with Oropharyngeal Squamous Cell Carcinoma: Impact of the Tumor HPV Status
![Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places](https://www.researchgate.net/publication/363715730/figure/fig1/AS:11431281085601245@1663792667202/Cabozantinib-inhibits-migration-invasion-and-proliferation-of-HNSCC-cells-A-CAL33RR_Q320.jpg)
Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places
![Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places](https://www.researchgate.net/publication/363715730/figure/fig2/AS:11431281085603336@1663792667349/Cabozantinib-induces-cell-cycle-arrest-polyploidy-and-cell-death-A-33-33R-33xR-and_Q320.jpg)
Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places
![Cancers | Free Full-Text | Current Therapeutic Strategies in Patients with Oropharyngeal Squamous Cell Carcinoma: Impact of the Tumor HPV Status Cancers | Free Full-Text | Current Therapeutic Strategies in Patients with Oropharyngeal Squamous Cell Carcinoma: Impact of the Tumor HPV Status](https://www.mdpi.com/cancers/cancers-13-05456/article_deploy/html/images/cancers-13-05456-g001.png)
Cancers | Free Full-Text | Current Therapeutic Strategies in Patients with Oropharyngeal Squamous Cell Carcinoma: Impact of the Tumor HPV Status
![Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places](https://www.researchgate.net/publication/344212470/figure/fig2/AS:960116643872769@1605921054060/Members-of-staff-PCI-HN-number-of-patients-selecting-each-member-of-staff-when-asked_Q320.jpg)
Alexandre Bozec's research works | Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice (IUFC) and other places
Avis sur Institut universitaire de la face et du cou - Centres médicaux - Provence-Alpes-Côte d'Azur
Editorial board - European Annals of Otorhinolaryngology, Head and Neck Diseases | ScienceDirect.com by Elsevier
![MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. - Abstract - Europe PMC MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5593634/bin/oncotarget-08-57174-g001.jpg)
MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. - Abstract - Europe PMC
![MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. - Abstract - Europe PMC MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5593634/bin/oncotarget-08-57174-g005.jpg)
MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. - Abstract - Europe PMC
Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfun
![The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy](https://www.thno.org/v11/p9571/toc.jpg)
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy
![The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy](https://www.thno.org/v11/p9571/thnov11p9571g002.jpg)